bezafibrate has been researched along with Hyperinsulinism in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Fan, S; Jin, X; Wang, L; Xie, X; Xue, N | 1 |
| Kotake, H | 1 |
| Fujioka, Y; Iwasaki, T; Masai, M; Morimoto, S; Ohyanagi, M; Okumura, T; Tsuboi, S; Tsujino, T | 1 |
| Carmody, MW; Davidoff, AJ; Davidson, MB; Hintz, KK; Mason, MM; Podolin, DA; Ren, J; Wold, LE | 1 |
| Fukamachi, I; Hashimoto, H; Kobayashi, J; Niihara, K; Saito, Y; Sasaki, N; Shirai, K; Takahashi, K; Tashiro, J; Yoshida, S | 1 |
| Kühnle, HF; Pill, J | 1 |
| Richey, JM; Si, X; Webb, RC | 1 |
1 review(s) available for bezafibrate and Hyperinsulinism
| Article | Year |
|---|---|
[Syndrome X].
Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Leptin; Life Style; Metabolic Syndrome; Pioglitazone; Thiazoles; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2002 |
6 other study(ies) available for bezafibrate and Hyperinsulinism
| Article | Year |
|---|---|
Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.
Topics: Animals; Bezafibrate; Cricetinae; Diet, High-Fat; Drug Design; Gene Expression Regulation; Hyperinsulinism; Hyperlipidemias; Hypolipidemic Agents; Liver; Male; Muscle, Skeletal; Pentanoic Acids; PPAR alpha; Resveratrol; Sirtuin 1; Stilbenes; Triglycerides | 2014 |
Troglitazone reduces activity of the Na+/H+ exchanger in fructose-fed borderline hypertensive rats.
Topics: Animals; Bezafibrate; Blood Glucose; Blood Platelets; Blood Pressure; Calcium; Chromans; Diet; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Fructose; Hydrogen-Ion Concentration; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Male; Propionates; Rats; Sodium-Hydrogen Exchangers; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Vasodilator Agents | 2003 |
Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments.
Topics: Animals; Bezafibrate; Diabetes Mellitus, Type 2; Dietary Sucrose; Heart Diseases; Hyperinsulinism; Hypolipidemic Agents; Insulin Resistance; Male; Myocardial Contraction; Myocytes, Cardiac; Physical Conditioning, Animal; Physical Exertion; Rats; Rats, Wistar | 2004 |
Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
Topics: Adult; Aged; Bezafibrate; Blood Glucose; Female; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Immunoenzyme Techniques; Insulin; Lipase; Lipoprotein Lipase; Liver; Male; Middle Aged; Triglycerides | 1994 |
BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity.
Topics: Adipocytes; Animals; Bezafibrate; Blood Glucose; Cells, Cultured; Hyperinsulinism; Hypoglycemic Agents; Hypolipidemic Agents; Lauric Acids; Lipid Metabolism; Male; Mice; Mice, Obese; Rats; Rats, Zucker | 1999 |
Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Bezafibrate; Blood Pressure; Body Weight; Calcium Channel Agonists; Dose-Response Relationship, Drug; Fructose; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypolipidemic Agents; In Vitro Techniques; Lipoproteins, VLDL; Male; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1999 |